Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sha Tian

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Biorxiv : the Preprint Server for Biology|April 2, 2024
Metastatic site influences driver gene function in pancreatic cancerKaloyan M Tsanov, Francisco M Barriga, Yu-Jui Ho, et al.
Cell Research|October 28, 2022
Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumorsFan Zhang, Qilin Zhang, Jiajun Zhu, et al.
Nature Communications|November 8, 2022
Author Correction: Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals potential therapeutic strategiesYan Li, Chen Xu, Bing Wang, et al.
Nature Communications|September 29, 2022
Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals new therapeutic strategiesYan Li, Chen Xu, Bing Wang, et al.
Nature Communications|November 30, 2022
Integrated proteomic and transcriptomic landscape of macrophages in mouse tissuesJingbo Qie, Yang Liu, Yunzhi Wang, et al.
Journal of Hematology & Oncology|November 26, 2022
Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinomaYexin Tong, Mingjun Sun, Lingli Chen, et al.
Science (New York, N.Y.)|December 22, 2018
NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combinationMarcus Ruscetti, Josef Leibold, Matthew J Bott, et al.
Blood|January 10, 2025
α-Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemiaScott E Millman, Almudena Chaves-Perez, Sudha Janaki-Raman, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2022
A preclinical platform for assessing antitumor effects and systemic toxicities of cancer drug targetsXiang Li, Chun-Hao Huang, Francisco J Sánchez-Rivera, et al.
Nature Cancer|September 25, 2025
SMAD4 induces opposite effects on metastatic growth from pancreatic tumors depending on the organ of residenceKaloyan M Tsanov, Francisco M Barriga, Yu-Jui Ho, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Biorxiv : the Preprint Server for Biology|April 2, 2024
Metastatic site influences driver gene function in pancreatic cancerKaloyan M Tsanov, Francisco M Barriga, Yu-Jui Ho, et al.
Cell Research|October 28, 2022
Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumorsFan Zhang, Qilin Zhang, Jiajun Zhu, et al.
Nature Communications|November 8, 2022
Author Correction: Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals potential therapeutic strategiesYan Li, Chen Xu, Bing Wang, et al.
Nature Communications|September 29, 2022
Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals new therapeutic strategiesYan Li, Chen Xu, Bing Wang, et al.
Nature Communications|November 30, 2022
Integrated proteomic and transcriptomic landscape of macrophages in mouse tissuesJingbo Qie, Yang Liu, Yunzhi Wang, et al.
Journal of Hematology & Oncology|November 26, 2022
Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinomaYexin Tong, Mingjun Sun, Lingli Chen, et al.
Science (New York, N.Y.)|December 22, 2018
NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combinationMarcus Ruscetti, Josef Leibold, Matthew J Bott, et al.
Blood|January 10, 2025
α-Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemiaScott E Millman, Almudena Chaves-Perez, Sudha Janaki-Raman, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2022
A preclinical platform for assessing antitumor effects and systemic toxicities of cancer drug targetsXiang Li, Chun-Hao Huang, Francisco J Sánchez-Rivera, et al.
Nature Cancer|September 25, 2025
SMAD4 induces opposite effects on metastatic growth from pancreatic tumors depending on the organ of residenceKaloyan M Tsanov, Francisco M Barriga, Yu-Jui Ho, et al.
Pageof 10